, Tracking Stock Market Picks
Enter Symbol:
Devry Inc. (DV) [hlAlert]

Buy DV
up 5.01 %

Devry Inc. (DV) upgraded to Buy with price target $32 by Standpoint Research

Posted on: Friday,  Aug 21, 2015  10:25 AM ET by Standpoint Research

Standpoint Research rated Buy Devry Inc. (NYSE: DV) on 08/21/2015, when the stock price was $25.72. Since
then, Devry Inc. has gained 5.02% as of 01/26/2016's recent price of $27.01.
If you would have followed this Standpoint Research's recommendation on DV, you would have gained 5.01% of your investment in 158 days.

DeVry Inc. (DeVry), through its wholly owned subsidiaries, owns and operates DeVry University, Ross University, Chamberlain College of Nursing, U.S. Education, Becker Professional Education and Advanced Academics. The Company operates in four segments: Business, Technology and Management, which comprises the DeVry University; Medical and Healthcare, which comprises Ross University, Chamberlain College of Nursing and U.S. Education; Professional Education, which comprises Becker Professional Education, and Other Educational Services, which comprises Advanced Academics and Fanor. On September 18, 2008, DeVry acquired U.S. Education. On April 1, 2009, the Company acquired an 82.3% interest in Fanor, a provider of private postsecondary education in northeastern Brazil.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/21/2015 10:25 AM Buy
25.72 32.00
as of 8/27/2015
1 Week up  5.01 %
1 Month up  5.01 %
3 Months up  5.01 %
1 YTD up  5.01 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/23/2013 10:25 AM Hold
3/12/2012 2:25 PM Buy
34.90 45.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy